Navigation Links
Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
Date:5/7/2009

Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that the MATRIX study or other human clinical trials can be conducted and completed in an efficient and successful manner, that product formulation enhancements will be successful or will effectively simplify or expand the use of product candidates or technologies, that the GAM technology can be successfully broadened or applied to additional wound healing or tissue repair opportunities, that Excellarate or our other candidates will prove to be sufficiently safe and effective, that results or trends observed in one clinical study or procedure will be reproduced in subsequent studies or procedures, that clinical studies even if successful will lead to product advancement or partnering, that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive, that FDA, CE Mark or other regulatory clearances or UL or other certifications, or partnering or other distribution agreements or other commercialization efforts will be successful or will effectively accelerate the business or market, that product modifications or launches will be successful or that the resulting products will be favorably received in the marketplace, that our products or product candidates will prove to be sufficiently safe and effective after introduction into a broader patient population, or that third parties on whom we depend will perform as anticipated.

Actual results may also differ substantially from those described in or contemplated by this press release due t
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. An international first at the CHUM - Promising treatment in regeneration of the myocardium through the use of stem cells
2. Cardium Reports on Recent Highlights and Financial Results
3. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
4. Cardium Announces InnerCools Endovascular Cooling to be Featured on Science Channels Series Cool Stuff: How It Works
5. Cardium Completes $6.0 Million Financing
6. Cardium Announces Investor Presentation and Corporate Update Webcast
7. Cardium Reports on New York Citys Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients
8. Cardium Reports on Exchange Listing With NYSE Alternext US
9. Cardiums InnerCool Announces Launch of New Enhanced Website
10. Cardiums InnerCool Reports on Expanding Use of Therapeutic Hypothermia
11. Cardiums Exchange Listing Compliance Plan Accepted by NYSE Alternext US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... ... August 30, 2015 , ... SonaCare ... for the treatment of prostate cancer, has announced the roll-out of its newest ... treatment center in Puerto Vallarta, Mexico. , The Sonablate® technology currently in use ...
(Date:8/29/2015)... ... 29, 2015 , ... "I have been a licensed physical ... specialize in manual therapy, and my invention will provide headache sufferers a solution ... muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, ...
(Date:8/29/2015)... ... , ... Next weekend is Labor Day weekend, the last bash of the ... this year). For IT security personnel, it should also mark the perfect time to ... costly than a simple headache. , Joe Caruso, founder and CEO-CTO of Global ...
(Date:8/29/2015)... , ... August 29, 2015 , ... ... company to freely market and sell Arterosil and Arterosil HP, and that all ... LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United States District ...
(Date:8/28/2015)... Richey, FL (PRWEB) , ... August 28, 2015 , ... ... many potential workers are qualified for the position they are applying for, they are ... of this, many employers are considering altering drug testing policies in order to be ...
Breaking Medicine News(10 mins):Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4
... or no protection from harmful rays emitted by the sun ... style may even risk blindness, warn scientists in Britain. ... to this radiation may severely affect the skin, eyes or ... adults often choose sunglasses purely on the basis of their ...
... invariably heavier than others. Researchers at the US ... and Prevention and the Cincinnati Children's Hospital say ... such a phenomenon. ,Other studies have already shown ... in early life. ,However, this study is ...
... can be very unhealthy for the skin. The skin absorbs ... the usage of daily makeup. Mr. Richard Bence, a biochemist, ... they get absorbed straight into the bloodstream. ,Women, across the ... best, but this excessive use is leading to a chemical pile ...
... sperms stocked by Indian sperm banks are at a ... much Islamist or Talibanized, infertile Afghan couple do scout ... ,Ironically it is perhaps the never-ending conflicts, ... to stress-related hormonal disturbances in Afghans. And such imbalances ...
... the first scientific review of a dozen patients who have ... gene therapy technique is safe and may be effective at ... patients, half of whom live on Long Island, are in ... to medicines when they signed on for the experimental therapy. ...
... study has claimed that being employed on the moon ... depression and anxiety. ,According toChester Spell, an ... Business-Camden, the lunar settlements of tomorrow - or, for ... long-term implications for the mental health of employees working ...
Cached Medicine News:Health News:Wear Protective Sunglasses, Not Just for Style 2Health News:Autism Could Be Related to Higher Level of Growth Hormones 2Health News:Make Up Unhealthy for Skin 2Health News:Afghan Couple Turn to Indian Sperm Banks for Help 2Health News:Gene Therapy for Parkinsons Disease 2
(Date:8/28/2015)... , Aug. 28, 2015 Patterson ... Inc. (Nasdaq: PDCO ), is now an ... announced acquisition of Patterson Medical by Madison Dearborn ... retain its name for a transition period before ... rehabilitation and sports medicine products.  With the focused ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "Investigation Report ... their offering. Developed by Pharmacia & ... receptor agonist which effectively reduces intraocular pressure. As ... latanoprost (under the trade name of Xalatan) entered ...
(Date:8/28/2015)... Shakti, LLC, today announced that it has changed its name ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... our transformation into a company focused on patent claim analysis ... validity." In ... the Company commenced a corporate re-branding initiative in order to ...
Breaking Medicine Technology:Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3China Latanoprost Market Investigation Report 2015-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2
... , MONTREAL, Oct. 14 During tough economic times, ... Global Vision,s automated inspection solutions in an effort to ... products. , First Priority,s previous method of inspection ... secondary packaging. Along with manual inspection came heavy labor ...
... N.J., Oct. 14 Weekly Digest ( http://www.bullmarket.com/digest ... publication of a special report on investment opportunities in ... updated outlooks for Gilead Sciences (Nasdaq: GILD ), ... DVAX ), Hemispherx BioPharma (Amex: HEB ), ...
Cached Medicine Technology:Global Vision Helps First Priority Reduce Costs in Tough Times 2Weekly Digest's Investor Essentials Special Report Identifies Unique Investing Opportunities in the H1N1 'Swine Flu' Outbreak 2
Anti-PR3 EIA Auto-Immune Markers 013-PR3-48 Proteinase...
GBM -Ab EIA Auto-Immune Markers 013-GBM-96 Glomerular Basement Membrane...
... Insulin-like growth factor 1 (IGF-1) is a polypeptide ... one of a number of related insulin-like growth ... approximately 50% sequence homology with proinsulin and has ... The peptide is growth hormone (GH) dependent to ...
...
Medicine Products: